Similarly, the combination of NfL and GFAP did not significantly increase the diagnostic power of distinguishing premanifest and manifest HD participants (AUC = 0.976, 95% CIs for AUC: 0.934–1.000, p < 0.0001; Figure 1G). The gene discussed is GFAP; the disease is Huntington disease.